April 22, 2024
Scientists are developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Genetically engineering a treatment for incurable brain tumors
April 22, 2024
Researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking method in immunotherapy drug development, utilizing engineered peptides that stimulate the body’s immune system to fight cancer more effectively. Published in Nature Biomedical Engineering, their study presents a promising leap forward in treating advanced breast cancer, showcasing enhanced tumor suppression and extended survival rates.
Breakthrough in Cancer Treatment: Novel Engineered Peptides Enhance Immunotherapy Efficacy
April 22, 2024
In a significant milestone for the Purdue Institute for Cancer Research (PICR), faculty, students and staff gathered at the Hansen Life Sciences Research Building on April 17 to honor seven awardees for their outstanding contributions to cancer research. PICR Director Andrew Mesecar delivered remarks emphasizing the importance of establishing the awards ceremony as a tradition and spoke about the distinct contributions each recipient had made to further the institute’s goal of conquering cancer.
First annual PICR Awards ceremony recognizes excellence in cancer research
April 21, 2024
In a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have developed a new method for creating immunotherapy drugs using engineered peptides. The study showed that the method improved tumor control and prolonged survival in preclinical models of locally advanced and metastatic breast cancer, both as a monotherapy and in combination with immune checkpoint inhibitors.
New study paves the way for advancements in immunotherapy drug development
April 12, 2024
D. Marshall Porterfield’s proposal for a lunar plant growth experiment was selected by NASA for the Artemis 3 moon mission. Read more about the experiment: Artemis 3 to include Space Lab’s LEAF Plant Science Experiment.
Dr. Porterfield and Colleagues’ Experiment Selected for Artemis 3 Mission
April 12, 2024
World Parkinson’s Day is an annual global healthcare event to recognize the cultural, economic, and social impact of Parkinson’s disease. This year, April 11 was designated as World Parkinson’s Day, which also focuses on advancing the acceptance, inclusion, and support of people affected by the disease. In recognition of the day, Purdue University spotlighted research by Dr. Jessica Fortin, assistant professor of basic medical sciences, physiology and pharmacology in the College of Veterinary Medicine’s Department of Basic Medical Sciences.
Purdue University Recognizes World Parkinson’s Day by Highlighting Research Led by PVM Scholar
April 12, 2024
We all know that toxic relationships can be damaging in the moment. But did you know they can also have long-term effects that linger for years?
8 surprising ways a toxic relationship can affect you years later, according to psychology
April 11, 2024
New spectrometer helps identify alternative catalyst materials for affordable hydrogen fuel cells. Fuel cells are quickly becoming a viable, clean energy alternative to commonly used fossil fuels, such as gasoline, coal, and oil. Fossil fuels are non-renewable energy resources that release carbon dioxide into the atmosphere.
New spectrometer helps identify alternative catalyst materials for affordable hydrogen fuel cells
April 11, 2024
The National Science Foundation has awarded a $275,000 Phase 1 Small Business Innovation Research (SBIR) grant to Amplified Sciences. The clinical-stage life sciences diagnostic company is developing tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer.
NSF awards $275K grant to Amplified Sciences to develop new platform of ultrasensitive clinical diagnostics
April 10, 2024
Fuel cells are quickly becoming a viable, clean energy alternative to commonly used fossil fuels, such as gasoline, coal, and oil. Fossil fuels are non-renewable energy resources that release carbon dioxide into the atmosphere.
New spectrometer helps identify alternative catalyst materials for affordable hydrogen fuel cells
